31 – 40 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Health economic evaluation of the Lund Integrated Medicines Management Model (LIMM) in elderly patients admitted to hospital.
(
- Contribution to journal › Article
-
Mark
Målriktad behandling av bröstcancer
2013)(
- Other contribution › Miscellaneous
-
Mark
A Candidate Gene Approach to ANCA-Associated Vasculitis Reveals Links to the C3 and CTLA-4 Genes but not to the IL1-Ra And Fcγ-RIIa Genes.
(
- Contribution to journal › Article
-
Mark
Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature.
(
- Contribution to journal › Article
-
Mark
Acute pancreatitis - costs for healthcare and loss of production.
(
- Contribution to journal › Article
-
Mark
Medicinska framsteg i behandling av kronisk myeloisk leukemi
2013)(
- Other contribution › Miscellaneous
- 2012
-
Mark
A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing.
(
- Contribution to journal › Article
-
Mark
Budget impact analysis of surgical treatment for obesity in sweden.
(
- Contribution to journal › Article
-
Mark
Drug and treatment costs in Parkinson's disease patients in Sweden.
(
- Contribution to journal › Article
-
Mark
Switch to Biological Agent in Psoriasis Significantly Improved Clinical and Patient-Reported Outcomes in Real-World Practice
(
- Contribution to journal › Article